November 10, 2025 - 19:00
Neurelis, Inc. has announced its participation in the 13th Annual Sofie's Journey Epilepsy Awareness Day and Education Expo, taking place at the iconic Disneyland Resort. This event aims to raise awareness about epilepsy and provide education to families affected by the condition.
The expo will feature a variety of activities, including informative sessions, interactive exhibits, and opportunities for attendees to connect with healthcare professionals and support organizations. Neurelis, known for its commitment to improving the lives of individuals with epilepsy, will showcase its innovative treatment options, including VALTOCO® (diazepam nasal spray), which is designed for the rescue treatment of seizure clusters.
The event is expected to attract a diverse audience, including patients, caregivers, and advocates, all united in their mission to enhance understanding and support for those living with epilepsy. Neurelis is proud to be part of this important initiative, emphasizing the significance of community engagement in addressing the challenges faced by individuals with epilepsy.
